Format

Send to

Choose Destination
Gynecol Endocrinol. 2018 Apr;34(4):294-297. doi: 10.1080/09513590.2017.1395835. Epub 2017 Nov 5.

The relationship between IL-18 and atherosclerotic cardiovascular risk in Egyptian lean women with polycystic ovary syndrome.

Author information

1
a Internal Medicine , Menoufia University , Shebin El-Kom , Egypt.
2
b Obstetrics and Gynecology , Faculty of Medicine-Menoufia University , Shebin El-Kom , Egypt.
3
c Clinical Pathology , Menoufia University , Shebin El-Kom , Egypt.

Abstract

BACKGROUND:

Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder among women of reproductive age. The evidence in support of low-grade inflammation in PCOS as an etiology is emerging. Inflammation is likely to be associated with other prominent aspects of PCOS including insulin resistance (IR) and cardiovascular disease (CVD) risk. Interleukin-18 (IL-18) is considered as a strong marker of inflammation.

OBJECTIVES:

Evaluation of the relation between serum IL-18 and atherosclerotic CVD (ASCVD) risk in Egyptian lean females with PCO.

METHODS:

This study included control group of healthy lean normally menstruating females, lean PCOS group (BMI < 25 kg/m2), and obese PCOS group (BMI > 25 kg/m2) presented with infertility and diagnosed according to Rotterdam criteria. Measurements of serum lipid profile, IR, and IL-18 were done.

RESULTS:

Lipid accumulation product (LAP), IR and ASCVD risk were significantly higher in PCOS patients (lean and obese) compared to controls and in obese compared to lean. Serum IL-18 was significantly higher in the PCOV groups compared to the controls and correlated directly with LAP, IR and ASCVD risk.

CONCLUSION:

IL-18 is elevated in PCOS patients even in lean ones and is correlated with IR and ASCVD risk.

KEYWORDS:

Polycystic ovary; cardiovascular disease risk; interleukin-18

PMID:
29105530
DOI:
10.1080/09513590.2017.1395835
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center